A recently identified EBV circRNA, circLMP-2A, which is formed through the backsplicing of exon 5 to exon 3 of the LMP-2A gene, was reported to promote cancer stemness properties of EBV-associated gastric carcinoma cells through a circLMP-2A/miR-3908/TRIM59/p53 axis22. The gene discussed is TP53; the disease is gastric carcinoma.